Emerging opportunities and challenges in small molecule development for non-HSP90 chaperones

Area of Science:

• Molecular Biology
• Drug Discovery
• Biochemistry

Background:

• Heat shock proteins (HSPs) are crucial for maintaining proteostasis.
• Dysregulation of HSPs is linked to diseases like cancer and neurodegeneration.
• HSP90 inhibitors show therapeutic promise, particularly in oncology.

Purpose of the Study:

• To review small-molecule inhibitors targeting non-HSP90 families.
• To highlight the therapeutic potential and mechanisms of these inhibitors.
• To identify challenges and future directions in targeting HSPs.

Main Methods:

• Systematic review of literature on non-HSP90 inhibitors.
• Analysis of therapeutic potential and mechanisms of action.
• Exploration of medicinal chemistry and structural biology approaches.

Main Results:

• Development of small-molecule inhibitors against HSP110, HSP70, HSP60, HSP40, and HSP27.
• Identification of unique mechanisms for these non-HSP90 targets.
• Progress made in targeting these chaperones, though challenges remain.

Conclusions:

• Non-HSP90 chaperones represent underexplored but critical drug targets.
• Small-molecule inhibitors offer significant therapeutic potential for various diseases.
• Future innovation in medicinal chemistry and structural biology is key for drug discovery.